AngII receptor type 2 (AT2) is generally considered to be an antagonist of the AT1 receptor, regulating the relaxation of the smooth muscle (92)
Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimers disease
Your body's most powerful detoxifier
GLP-1 Drugs: A Potential Game-Changer for RA, Psoriasis and PsA Recent studies have unveiled exciting potential for GLP-1 drugs like Ozempic, Mounjaro, and Zepbound in treating autoimmune conditions such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and psoriasis
GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice